Australia is on track in only two of the seven focus areas of its National Preventive Health Strategy at the strategy’s midpoint, according to a first-of-its-kind review published by the Royal Australian College of GPs (RACGP) — and the college says the nation will not reach its 2030 goals without a major funding lift for longer GP consultations.
The RACGP’s midway review of general practice’s contributions to the National Preventive Health Strategy 2021–2030 found that only tobacco control and physical activity are on track. Cancer screening and immunisation were rated mixed, while healthy diet, alcohol and other drug harm, and mental health were all rated not on track. Of the strategy’s broader aims, the college marked healthy life expectancy and prevention investment as not on track, best start in life as mixed, and health equity as having no updated data.
The college says Australia will not reach its preventive health goals without a 40 per cent increase in Medicare rebates for long GP consultations — Level C and Level D items — alongside stronger primary care data collection and multidisciplinary care teams. With general practice contributing to all seven focus areas, the RACGP said GPs played a “critical role” in achieving the strategy’s goals, but that role needs proper funding.
The review’s case rests in part on the sheer scale of general practice. GPs provided 172 million health services to 22.6 million patients in 2025. They also delivered the largest share of maternal RSV vaccinations, at 42 per cent compared with approximately 15 per cent from pharmacists — and RSV-associated hospitalisations among infants under three months of age declined by 43.8 per cent in the program’s first year in 2025. GPs delivered more than 188,000 nicotine and smoking cessation counselling services between 2021 and 2024, with a 16-fold increase in cessation consultations while MBS items were available.
With five years remaining in the strategy, the college said expanding preventive capacity could speed progress — but the barriers are substantial. Broader health determinants can limit preventive behaviours and access to healthcare due to social or economic disadvantage, geographic isolation, low health literacy and cost barriers. Yet these same disadvantaged communities were often more likely to experience multimorbidity and chronic disease, which often led to healthcare delays or an inability to fully follow healthcare advice, affirming the critical need for affordable care.
Funding for preventive healthcare, including longer consultations, had not kept pace with increasingly complex care, the report found. Workforce shortages, especially in rural, remote and socioeconomically disadvantaged areas, also limited preventive discussions. And attaining increased funding was especially difficult when preventive initiatives often took years or decades to demonstrate measurable outcomes, making them harder to prioritise within short political and funding cycles.
Data gaps compound the problem. Despite successful programs like Preventing Heart Attacks and Stroke Events through Surveillance, which flags patients at elevated cardiovascular risk, limited interoperability and data capabilities left many practices unable to identify high-risk patients, recall them for preventive care, or track outcomes.
The review argues that sustained investment in community services and referral pathways is needed to address the underlying social determinants of health inequity — and that without it, the 2030 targets will slip further out of reach.
